G
Germana Castelli
Researcher at Istituto Superiore di Sanità
Publications - 69
Citations - 2780
Germana Castelli is an academic researcher from Istituto Superiore di Sanità. The author has contributed to research in topics: Myeloid leukemia & Haematopoiesis. The author has an hindex of 26, co-authored 57 publications receiving 2147 citations. Previous affiliations of Germana Castelli include Thomas Jefferson University.
Papers
More filters
Journal ArticleDOI
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies
TL;DR: In this paper , the development of molecular analysis techniques has led to the definition of the molecular alterations observed in esophageal cancer, consistently differing from those observed in EAC.
Journal ArticleDOI
TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
TL;DR: In this article , the authors investigated the role played by TP53 mutations in the pathogenesis of these myeloid disorders and in the mechanisms of drug resistance, and proposed new immune and non-immune strategies to improve survival and increase the number of TP53-mutated MDS/AML patients in remission.
Journal ArticleDOI
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Gianfranco Catalano,Alessandra Zaza,Cristina Banella,Elvira Pelosi,Germana Castelli,Elisabetta De Marinis,Ariela Smigliani,Serena Travaglini,Tiziana Ottone,Mariadomenica Divona,Maria Ilaria Del Principe,Francesco Buccisano,Luca Maurillo,Emanuele Ammatuna,Ugo Testa,Clara Nervi,Adriano Venditti,Maria Teresa Voso,Nélida I. Noguera +18 more
Journal ArticleDOI
The clinical value of identifying genetic abnormalities that can be targeted in cholangiocarcinomas
TL;DR: In this article , the authors provide an updated analysis of studies of genetic characterization of CCA at the level of gene mutation profiling, copy number alterations and gene expression, with definition of molecular subgroups and identification of some molecular biomarkers and therapeutic targets.